PANUZZO, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 3.076
EU - Europa 1.426
AS - Asia 670
AF - Africa 8
OC - Oceania 8
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.194
Nazione #
US - Stati Uniti d'America 3.047
IT - Italia 462
CN - Cina 390
IE - Irlanda 208
SE - Svezia 138
FR - Francia 124
UA - Ucraina 93
DE - Germania 87
FI - Finlandia 86
VN - Vietnam 73
JP - Giappone 67
AT - Austria 57
DK - Danimarca 52
KR - Corea 45
PL - Polonia 44
GB - Regno Unito 31
IN - India 21
SG - Singapore 21
CA - Canada 19
BE - Belgio 17
HK - Hong Kong 16
TR - Turchia 11
AU - Australia 8
TW - Taiwan 8
SN - Senegal 7
CH - Svizzera 6
MX - Messico 5
NL - Olanda 5
PR - Porto Rico 5
IR - Iran 4
ES - Italia 3
IL - Israele 3
IQ - Iraq 3
PT - Portogallo 3
RS - Serbia 3
AR - Argentina 2
BR - Brasile 2
EU - Europa 2
MO - Macao, regione amministrativa speciale della Cina 2
TH - Thailandia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HU - Ungheria 1
LI - Liechtenstein 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 5.194
Città #
Chandler 433
Fairfield 303
Beijing 249
Ann Arbor 245
Dublin 208
Torino 176
Ashburn 167
Houston 167
Woodbridge 159
Wilmington 147
Cambridge 124
Seattle 111
Villeurbanne 106
Nyköping 95
Jacksonville 76
Dearborn 74
Pisa 68
Vienna 57
Dong Ket 52
Princeton 52
Medford 47
Turin 47
Warsaw 44
Fremont 39
Boston 24
San Diego 20
Düsseldorf 19
New York 19
Brussels 17
Milan 16
Nanjing 16
Guangzhou 14
Redwood City 14
Munich 12
San Mateo 12
Shanghai 12
Washington 12
Boardman 10
Phoenix 10
Seoul 10
Hangzhou 9
Tokyo 9
Vadodara 9
Piemonte 8
Taipei 8
Toronto 8
Hefei 7
Hong Kong 7
Oswego 7
Silver Spring 7
Upper Marlboro 7
Xian 7
Isparta 6
San Mauro Torinese 6
Vestignè 6
Falls Church 5
Ottawa 5
Redmond 5
Singapore 5
Zhengzhou 5
Dallas 4
Edinburgh 4
Hebei 4
Nanchang 4
San Jose 4
Vercelli 4
Alpignano 3
Athens 3
Binasco 3
Bologna 3
Buffalo 3
Fuzhou 3
Harbin 3
Jinan 3
Kunming 3
Mexico 3
Mountain View 3
Napoli 3
Norwalk 3
Shenzhen 3
Arbil 2
Assago 2
Auburn University 2
Changchun 2
Chengdu 2
Cincinnati 2
Duncan 2
Evanston 2
Farmington 2
Fiumicino 2
Gainesville 2
Geneva 2
Glasgow 2
Gravina In Puglia 2
Hamilton 2
Heidelberg 2
Helsinki 2
Indore 2
Istanbul 2
Latrobe 2
Totale 3.725
Nome #
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 317
Morgana is a new oncosuppressor in CML 222
Non-Oncogene Addiction to BRD in CLL: from JQ1 Response to Resistence 197
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation 173
Curcumin induces apoptosis in JAK2-mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways 169
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias 168
BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia. 164
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia 163
Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection 143
Deferasirox-dependent iron chelation enhances mitochondrial dysfunction and restores p53 signaling by stabilization of p53 family members in leukemic cells 138
Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1 138
The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia 133
Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe. 131
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 114
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias 113
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. 111
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study 111
Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients 106
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase 104
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML 101
A short evolutionary journey across the HERC Ubiquitin Ligases 101
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion 96
Reduced Expression of Sprouty1 Contributes to the Aberrant Proliferation and Impaired Apoptosis of Acute Myeloid Leukemia Cells 94
ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML 92
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 91
Escaping from hypoxia to enjoy normoxia: insights from the social amoeba Dictyostelium 89
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches 89
BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP 80
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS 80
MORGANA/CHP1 ACTS AS AN ONCOSUPPRESSOR IN CHRONIC MYELOID LEUKEMIA 79
HAUSP compartmentalization in chronic myeloid leukemia 76
Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia 76
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY 74
Two conserved glycine residues in mammalian and Dictyostelium Rictor are required for mTORC2 activity and integrity 70
Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients 69
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. 68
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia. 68
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 67
Out of frame peptides from BCR/ABL alternative splicing are immunogenic in HLA A2.1 transgenic mice 64
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA 63
Morgana haploinsufficiency induces a myeloproliferative disorder like-chronic myeloid leukemia in mice. 62
IκB-α: At the crossroad between oncogenic and tumor-suppressive signals 58
Bcr-Abl p210 delocalizes PTEN through a PML/HAUSP network 57
The Dynamics of Aerotaxis in a Simple Eukaryotic Model 56
PNA: A Snapshot on their Applications in Leukemia Diagnosis and Research 52
The Role of PTEN in Myeloid Malignancies 49
Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia 49
Kinase-inhibitor–insensitive cancer stem cells in chronic myeloid leukemia 46
Characterization of a monoclonal antibody specific for novel Bcr/Abl out-of-frame fusion proteins. 46
The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding Partner 44
Untangling the functional roles of a large HERC1 E3-Ubiquitin Ligase in Dictyostelium and Leukemic Cells. 43
The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation 42
Reduced Expression of the Tumor Suppressor Spred-2 in Acute Myeloid Leukemia Patients 35
The dynamics of the directed migration in response to oxygen gradient in eukaryotic simple model 31
Study of PIA/Rictor Protein Stability using both Dictyostelium discoideum and Mammalian Models 29
Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling 28
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells 24
Present and Future Opportunities in Imaging the Ubiquitin System (Ub-System) 20
Totale 5.373
Categoria #
all - tutte 14.265
article - articoli 0
book - libri 0
conference - conferenze 4.854
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019218 0 0 0 0 0 0 0 0 0 0 159 59
2019/2020762 47 24 27 109 55 101 74 67 83 65 44 66
2020/2021971 54 65 69 72 119 108 94 46 75 69 68 132
2021/2022800 56 46 37 72 33 50 58 43 34 75 167 129
2022/20231.218 102 101 28 166 110 295 76 79 120 24 75 42
2023/2024332 63 88 33 23 19 50 8 26 2 18 2 0
Totale 5.373